tiprankstipranks
Trending News
More News >
RELIEF THERAPEUTICS Holding (RLFTF)
OTHER OTC:RLFTF

Compare RELIEF THERAPEUTICS Holding (RLFTF) vs. Competitors

Compare
304 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
RELIEF THERAPEUTICS Holding
$1.88
$278.96M
-1.16
-43.04%
Molecular Partners AG
CHF3.37
CHF134.45M
-2.05
-33.40%
0 Buy
1 Hold
0 Sell
Hold
Basilea Pharmaceutica
CHF54.10
CHF689.45M
9.47
39.24%
2 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.74
CHF952.55M
-5.71
414.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF26.75
CHF535.39M
22.33
200.22%
2 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF13.88
CHF184.55M
-2.59
0.15%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
RLFTF
RELIEF THERAPEUTICS Holding
2.42
-1.89
-43.85%
CH:MOLN
Molecular Partners AG
3.33
-1.77
-34.71%
CH:BSLN
Basilea Pharmaceutica
56.60
16.05
39.58%
CH:IDIA
Idorsia Ltd
3.82
3.05
401.31%
CH:NWRN
Newron Pharmaceuticals SpA
26.75
17.63
193.31%
CH:SANN
Santhera Pharmaceuticals Holding
13.26
-0.74
-5.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts